is glp 1 made from venom How a Canadian scientist and a venomous lizard helped pave the way for Ozempic Opinion | We Need to

Article Title : [Not specified in the provided content] News Publication Date : [Not specified in the provided content] Web References : doi:10.1001/jamahealthforum.2025.4258 Keywords : Peptides, Agonists, Cohort studies, Racial differences, Ethnicity, Medications, Pharmaceuticals, Health care costs, Health insurance Tags: chronic disease management inequalitieseconomic factors in medication adherenceGLP-1 receptor agonists prescription disparitiesglycemic control and weight managementhealthcare equity in pharmaceutical accessmedication adherence in type 2 diabetesnon-Hispanic Black and Hispanic health disparitiesout-of-pocket costs for diabetes medicationspolicy implications for diabetes careprescription fill rates by demographicrace and ethnicity in diabetes treatmentsystemic barriers in healthcare access

Even after recent price cuts, most states still face double-digit income burdens at mid-to high-tier prices, with annual out-of-pocket costs often exceeding $3,000 per year and reaching $4,000 or more at injectable maintenance prices

In recent years, weight-loss drugs have become a common addition to diet and exercise routines

The announcement comes a day after Eli Lilly and Novo Nordisk shares moved in opposite directions following their latest earnings reports, as Novo Nordisk warned of sales could decline this year, while Eli Lilly said its sales are expected to keep growing